ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $96 | -92.3% | 30,282 | -88.0% | 0.00% | -100.0% |
Q2 2023 | $1,252 | -40.9% | 251,900 | -41.2% | 0.00% | -33.3% |
Q1 2023 | $2,118 | -23.5% | 428,700 | -2.6% | 0.00% | -25.0% |
Q4 2022 | $2,768 | -100.0% | 440,100 | -54.8% | 0.00% | -60.0% |
Q1 2022 | $8,880,000 | -51.7% | 974,700 | +38.4% | 0.01% | -56.5% |
Q2 2021 | $18,371,000 | +480.6% | 704,400 | +739.6% | 0.02% | +666.7% |
Q3 2020 | $3,164,000 | +193.2% | 83,900 | +232.9% | 0.00% | +200.0% |
Q2 2020 | $1,079,000 | – | 25,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |